Komori
Other Disclosures4891TMS Co.,Ltd.Medicines

Notice of presentations on SMTP at the 41st Annual Meeting of the Japanese Society for Diabetic Complications and the 56th Annual Meeting of the Japanese Society for Wound Healing

The company announced plans to give oral presentations jointly with Showa Medical University at 2 academic conferences on research findings concerning SMTP compounds, particularly SMTP-44D. The presentations will address the mechanisms regulating diabetic nephropathy and the wound-healing-promoting effects of SMTP compounds on diabetic wounds.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

SMTP compoundsSMTP-44D
Applicable field (uses covered by this announcement)
Diabetic nephropathyDiabetic woundsWound healing
Launch date21 November 2026 and 23 November 2026 (scheduled conference presentation dates)
Relationship between the counterparty and the company
TMS Co.,Ltd.4891
Relationship with the Company

A research relationship involving the joint analysis of the pharmacological effects of SMTP compounds.

CounterpartyEducational Corporation Showa Medical University

An educational corporation. The document lists research organisations, including the Graduate School of Showa Medical University and the Research Center for Pharmacological Sciences, as the presenters' affiliations. Location, representative, capital and date of establishment: Not disclosed.

Location (as indicated in this announcement)

19-40 Chuocho, Kagoshima, Kagoshima Prefecture (venue for the 41st Annual Meeting of the Japanese Society for Diabetic Complications), 1-1 Gakuendai, Kahoku, Ishikawa Prefecture (venue for the 56th Annual Meeting of the Japanese Society for Wound Healing)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

41st Annual Meeting of the Japanese Society for Diabetic Complications

56th Annual Meeting of the Japanese Society for Wound Healing

Announced details
ItemDetails
Names of Products / Services CoveredSMTP compounds, SMTP-44D
CounterpartyEducational Corporation Showa Medical University
Counterparty overviewAn educational corporation. The document lists research organisations, including the Graduate School of Showa Medical University and the Research Center for Pharmacological Sciences, as the presenters' affiliations. Location, representative, capital and date of establishment: Not disclosed.
Relationship with the CompanyA research relationship involving the joint analysis of the pharmacological effects of SMTP compounds.
Launch date21 November 2026 and 23 November 2026 (scheduled conference presentation dates)
Applicable areaDiabetic nephropathy, Diabetic wounds, Wound healing
Location19-40 Chuocho, Kagoshima, Kagoshima Prefecture (venue for the 41st Annual Meeting of the Japanese Society for Diabetic Complications), 1-1 Gakuendai, Kahoku, Ishikawa Prefecture (venue for the 56th Annual Meeting of the Japanese Society for Wound Healing)
Source41st Annual Meeting of the Japanese Society for Diabetic Complications, 56th Annual Meeting of the Japanese Society for Wound Healing
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the results of analyses of the pharmacological effects of SMTP compounds obtained through joint research.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of presentations on SMTP at the 41st Annual Meeting of the Japanese Society for Diabetic Complications and the 56th Annual Meeting of the Japanese Society for Wound Healing | TMS Co.,Ltd. (4891) timely disclosure | Komori